Corcept Therapeutics Announces Second Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HON
9. HTZ
10. JPM

Go back to Corcept Therapeutics Announces Second Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update

Corcept Therapeutics (CORT) Tops Q2 EPS by 6c; Raises Rev Outlook

August 1, 2017 4:14 PM EDT

Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of $0.13, $0.06 better than the analyst estimate of $0.07. Revenue for the quarter came in at $35.6 million versus the consensus estimate of $32.53 million.

2017 revenue guidance increased by $20 million, to $145-155 million.

For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.

... More